Disease Models & MechanismsNeurosciencePeer-reviewed journal article
Cerebellar Neuronal Dysfunction Accompanies Early Motor Symptoms in Spinocerebellar Ataxia Type 3
Kristin Mayoral-PalarziD, Andreia Neves‐CarvalhoiD, Sara Duarte‐SilvaiD, Daniela Monteiro‐FernandesiD, Patrı́cia MacieliD, Kamran KhodakhahiD
Abstract
Spinocerebellar Ataxia Type 3 (SCA3) is an adult-onset, progressive ataxia. SCA3 presents with ataxia before any gross neuropathology. A feature of many cerebellar ataxias is aberrant cerebellar output that contributes to motor dysfunction. We examined whether abnormal cerebellar output was present in the CMVMJD135 SCA3 mouse model and, if so, whether it correlated with the disease onset and progression. In vivo recordings showed that the activity of deep cerebellar nuclei neurons, the main output of the cerebellum, was altered. The aberrant activity correlated with the onset of ataxia. However, although the severity of ataxia increased with age, the severity of the aberrant cerebellar output was not progressive. The abnormal cerebellar output, however, was accompanied with non-progressive abnormal activity of their upstream synaptic inputs, the Purkinje cells. In vitro recordings indicated that alterations in both intrinsic Purkinje cell pacemaking and in their synaptic inputs contributed to abnormal Purkinje cell activity. These findings implicate abnormal cerebellar physiology as an early, consistent contributor to pathophysiology in SCA3, and suggest that the aberrant cerebellar output could be an appropriate therapeutic target in SCA3. Summary StatementIn a mouse model of Spinocerebellar ataxia type 3 aberrant cerebellar physiology is apparent early in disease, before overt neuronal pathology or neuronal death.
- organism: mouse
- assay: electronic health records
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- approach: experimental assay
- Citations
- 14
- FWCI
- 1.21
- Field percentile
- top 25%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- In vivo molecular signatures of cerebellar pathology in spinocerebellar ataxia type 3
Maria do Carmo Costa, Maria Radzwion, … Gülin Öz·Movement DisordersPeer-reviewed·Jul 4, 2020
- Establishment of spinocerebellar ataxia type 34 model mice accompanied by early glial activation and degeneration of cerebellar neurons
Yuri Morikawa-Yujiri, Kensuke Motomura, … Takahiro Seki·Journal of Pharmacological SciencesPeer-reviewed·Apr 24, 2026
- A novel Ataxin-3 knock-in mouse model mimics the human SCA3 disease phenotype including neuropathological, behavioral, and transcriptional abnormalities
Eva Haas, Rana Dilara Incebacak Eltemur, … Jeannette Hübener‐Schmid·bioRxiv·Feb 28, 2020
- Broad influence of mutant ataxin-3 on the proteome of the adult brain, young neurons, and axons reveals central molecular processes and biomarkers in SCA3/MJD using knock-in mouse model
Kalina Wiatr, Łukasz Marczak, … Maciej Figiel·Frontiers in Molecular NeurosciencePeer-reviewed·Jun 17, 2021
- A Core Pattern of Cerebellar and Brainstem Degeneration and Reduced Cerebrocerebellar Structural Covariance in Spinocerebellar Ataxia Type 3 (SCA3): MRI Volumetrics from ENIGMA-Ataxia
Jason W. Robertson, Isaac Mawusi Adanyeguh, … Carlos Roberto Hernandez-Castillo·bioRxiv·Aug 8, 2025
- The 5-HT1A receptor agonist NLX-112 rescues motor swimming deficits in Spinocerebellar Ataxia type 3 mice
Daniela Cunha‐Garcia, Bruna Ferreira-Lomba, … Adrian Newman‐Tancredi·bioRxiv·Sep 4, 2025